Unraveling the Epigenetic Basis of Liver Development, Regeneration and Disease.


Journal

Trends in genetics : TIG
ISSN: 0168-9525
Titre abrégé: Trends Genet
Pays: England
ID NLM: 8507085

Informations de publication

Date de publication:
08 2020
Historique:
received: 23 01 2020
revised: 10 05 2020
accepted: 11 05 2020
pubmed: 4 6 2020
medline: 27 5 2021
entrez: 4 6 2020
Statut: ppublish

Résumé

A wealth of studies over several decades has revealed an epigenetic prepattern that determines the competence of cellular differentiation in the developing liver. More recently, studies focused on the impact of epigenetic factors during liver regeneration suggest that an epigenetic code in the quiescent liver may establish its regenerative potential. We review work on the pioneer factors and other chromatin remodelers that impact the gene expression patterns instructing hepatocyte and biliary cell specification and differentiation, along with the requirement of epigenetic regulatory factors for hepatic outgrowth. We then explore recent studies involving the role of epigenetic regulators, Arid1a and Uhrf1, in efficient activation of proregenerative genes during liver regeneration, thus highlighting the epigenetic mechanisms of liver disease and tumor development.

Identifiants

pubmed: 32487496
pii: S0168-9525(20)30099-8
doi: 10.1016/j.tig.2020.05.002
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

587-597

Informations de copyright

Copyright © 2020 Elsevier Ltd. All rights reserved.

Auteurs

Filippo Macchi (F)

Program in Biology, New York University Abu Dhabi, PO Box 129188, Abu Dhabi, United Arab Emirates.

Kirsten C Sadler (KC)

Program in Biology, New York University Abu Dhabi, PO Box 129188, Abu Dhabi, United Arab Emirates. Electronic address: Kirsten.edepli@nyu.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH